RecruitingNot ApplicableNCT06175754

Laser Treatment of Reticular Leg Veins vs. Sclerotherapy

Treatment of Reticular Leg Veins: a Prospective, Randomized, Comparative Clinical Trial of a 1064 nm Nd:YAG Long Pulse Laser, Combined Treatment of a 1064 nm Nd:YAG Long Pulse Laser and Sclerotherapy vs. Sclerotherapy Alone.


Sponsor

Derzhavin Tambov State University

Enrollment

174 participants

Start Date

Oct 9, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Treatment of reticular veins with a 1064 nm long-pulsed Nd:YAG laser and combination of a 1064 nm Nd:YAG long pulse laser and sclerotherapy should be no less effective than sclerotherapy alone, and have a frequency of adverse events less then sclerotherapy alone.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years

Inclusion Criteria3

  • women over 18
  • reticular veins
  • signed informed consent to participate in the study

Exclusion Criteria10

  • diabetes mellitus
  • pregnancy or lactation
  • malignant neoplasms
  • inability or unwillingness of the patient to wear compression stockings
  • hypersensitivity to the polidocanol, cold, sunlight
  • concomitant diseases: bronchial asthma, severe liver and kidney disease, acute thrombosis and thrombophlebitis, infection of the skin and/or soft tissues, infectious diseases, arteriosclerosis, diabetic angiopathy, heart defects requiring surgery, fever, toxic hyperthyroidism, obesity, tuberculosis, sepsis, violation of the cellular composition of the blood, all diseases requiring bed rest, heart disease with decompensation phenomena,
  • known hereditary thrombophilia.
  • period after treatment of alcoholism
  • reception of oral contraceptives
  • sedentary lifestyle

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELaser ablation

Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, laser

PROCEDURELaser with Sclerotherapy

Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, laser plus sclerotherapy

PROCEDURESclerotherapy

Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, sclerotherapy


Locations(1)

Bukina Oksana Vasilyevna

Tambov, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06175754